# Identification of Manufacturing Establishments in Applications Submitted to CBER and CDER Questions and Answers – FDA Guidance

Source: https://www.keypedia.com/guidances/guidance-document/identification-of-manufacturing-establishments-in-applications-submitted-to-cber-and-cder-questions-and-answers/4f5d2866-e1a8-4a27-8196-db286649fbfb

> FDA guidance document: Identification of Manufacturing Establishments in Applications Submitted to CBER and CDER Questions and Answers. Issue date: October 22, 2019. Get complete insights and analysis.

---

## Details

- Title: Identification of Manufacturing Establishments in Applications Submitted to CBER and CDER Questions and Answers
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-10-22
- Last Changed: 2024-09-20
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-6821">FDA-2017-D-6821</a>

## Related Documents

- [Analytical Procedures and Methods Validation for Drugs and Biologics](https://www.keypedia.com/guidances/guidance-document/analytical-procedures-and-methods-validation-for-drugs-and-biologics/09d35164-7a70-4359-b2bc-338524a3d23c)
- [Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients Questions and Answers Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/q7-good-manufacturing-practice-guidance-for-active-pharmaceutical-ingredients-questions-and-answers-guidance-for-industry/1600b7d2-35c2-41f8-add1-35f8c98ddb9b)
- [E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers](https://www.keypedia.com/guidances/guidance-document/e2cr2-periodic-benefit-risk-evaluation-report-questions-and-answers/9735c0c5-468e-4e9b-a4c9-a7bad1eb9d94)